Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Motilal B. Pamnani"'
Autor:
Motilal B. Pamnani, Billy W. Day, Nikolai V. Gorbunov, James L. Atkins, Michael T. Handrigan, Zhe Zhang
Publikováno v:
Journal of Applied Physiology. 100:1267-1277
The results of previous inhibitor studies suggest that there is some increase in nitric oxide (NO) production from constitutive NO synthase in early hemorrhage (H), but the magnitude of NO production early after H has not been previously assessed. It
Autor:
S. Chen, Motilal B. Pamnani, Francis J. Haddy, Raj D. Ghai, James F. Schooley, Howard J. Bryant
Publikováno v:
Clinical and Experimental Hypertension. 22:45-62
Thiorphan, a neutral endoprotease (NEP) enzyme inhibitor, has been shown to enhance the effects of atrial natriuretic peptide (ANP) in vivo. In this study, we examined the effects of an intravenous (iv) infusion of thiorphan on cardiovascular hemodyn
Publikováno v:
Hypertension. 23:1046-1050
We have reported that streptozotocin-induced insulin-dependent diabetes mellitus in 25% reduced renal mass rats is associated with low-renin, volume-expanded hypertension and that the development of the hypertension can be prevented with insulin. In
Publikováno v:
Renal Failure. 15:33-36
We obstructed renal lymph drainage from a single kidney in diabetic rats who had received 65 mg/kg streptozotocin 6 months prior to the study. Lymphatic obstruction led to a progressive fall in systematic blood pressure from a mean arterial pressure
Publikováno v:
American Journal of Hypertension. 4:546S-555S
Autor:
Motilal B. Pamnani, H. J. Bryant, Francis J. Haddy, Diane C. Eliades, James F. Schooley, S. Chen, Christina M. Yuan
Publikováno v:
Hypertension. 18:316-324
Reports from several laboratories suggest the presence of an ouabainlike compound in plasma and various animal tissues, particularly during acute volume expansion and in low-renin hypertension. It has been hypothesized that this compound, through inh
Publikováno v:
American Journal of Hypertension. 3:188-195
Canrenone, a metabolic product of spironolactone, which competes with ouabain for binding to Na-K-ATPase at the digitalis receptor site and by itself inhibits Na-K-ATPase, was administered intramuscularly to reduced renal mass-saline drinking hyperte
Publikováno v:
The FASEB Journal. 21
Decompensation in hemorrhagic shock is the critical stage after which resuscitative efforts may prove futile. We hypothesize that decompensation results from potassium-mediated vasodilation and/or loss of cardiac contractility, and thus a method of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66c8096e3e230c82462f54c682d667a6
https://doi.org/10.21236/ada413516
https://doi.org/10.21236/ada413516
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 25(2)
We and others have shown that inhibition of cardiovascular muscle (CVM) cell Na+,K-ATPase activity (NKPTA) due to increased level of endogenous sodium potassium pump inhibitor (SPI) is involved in the mechanism of volume expanded (VE) experimental an